Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Allison

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
The Lancet. Gastroenterology & Hepatology|February 7, 2020
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation studyPhilip N Newsome, Magali Sasso, Jonathan J Deeks, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2026
Disordered Bile Acid Metabolism in Alcohol-Related HepatitisLuke D Tyson, Stephen Atkinson, Benjamin H Mullish, et al.
The American Journal of Gastroenterology|July 25, 2024
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver TransplantationBishoi Aziz, Beverley Kok, Matthew Cheah, et al.
European Journal of Endocrinology|June 2, 2017
Hypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinaseSarah M Leiter, Victoria E R Parker, Alena Welters, et al.
The American Journal of Gastroenterology|January 31, 2025
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver TransplantationBishoi Aziz, Beverley Kok, Matthew Cheah, et al.
Science Translational Medicine|December 3, 2020
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosisOlivier Govaere, Simon Cockell, Dina Tiniakos, et al.
Lancet (London, England)|March 14, 2021
New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UKRoger Williams, Charles Alessi, Graeme Alexander, et al.
Journal of Hepatology|March 8, 2021
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505-515)Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
Journal of Hepatology|March 15, 2023
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort<sup>☆</sup>" [J Hepatol (2020) 505-515]Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
Journal of Hepatology|April 17, 2020
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort<sup>☆</sup>Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
The Lancet. Gastroenterology & Hepatology|February 7, 2020
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation studyPhilip N Newsome, Magali Sasso, Jonathan J Deeks, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2026
Disordered Bile Acid Metabolism in Alcohol-Related HepatitisLuke D Tyson, Stephen Atkinson, Benjamin H Mullish, et al.
The American Journal of Gastroenterology|July 25, 2024
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver TransplantationBishoi Aziz, Beverley Kok, Matthew Cheah, et al.
European Journal of Endocrinology|June 2, 2017
Hypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinaseSarah M Leiter, Victoria E R Parker, Alena Welters, et al.
The American Journal of Gastroenterology|January 31, 2025
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver TransplantationBishoi Aziz, Beverley Kok, Matthew Cheah, et al.
Science Translational Medicine|December 3, 2020
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosisOlivier Govaere, Simon Cockell, Dina Tiniakos, et al.
Lancet (London, England)|March 14, 2021
New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UKRoger Williams, Charles Alessi, Graeme Alexander, et al.
Journal of Hepatology|March 8, 2021
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"☆ (J Hepatol [2020] 505-515)Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
Journal of Hepatology|March 15, 2023
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort<sup>☆</sup>" [J Hepatol (2020) 505-515]Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
Journal of Hepatology|April 17, 2020
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort<sup>☆</sup>Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
Pageof 10